Patent · US Active

Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof

US9241978B2 · kind B2 · utility

12Cited by

37References

21Claims

0Family size

Assignee

Biogen Hemophilia Inc. · US

Inventors

Jennifer A. Dumont · Groton, US
Susan Low · Pepperell, US
Alan J. Bitonti · Acton, US
Glenn Pierce · Cambridge, US
Alvin Luk · Boston, US
Haiyan Jiang · Belmont, US
Byron McKinney · San Diego, US
Matt Ottmer · Newton, US
Jurg Sommer · Wayland, US
Karen Nugent · Owlswick, GB
Lian Li · Lexington, US
Robert T. Peters · Needham, US

Key dates

Filing date	Mar 11, 2013
Grant date	Jan 26, 2016
Priority date	—
Expiry date	Aug 15, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods of administering Factor VIII; methods of administering chimeric and hybrid polypeptides comprising Factor VIII; chimeric and hybrid polypeptides comprising Factor VIII; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.